Concepts (207)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Nuclear Family | 1 | 2019 | 14 | 0.81 | Why? |
| Genome, Human | 2 | 2019 | 400 | 0.62 | Why? |
| Sequence Analysis, DNA | 5 | 2019 | 2830 | 0.54 | Why? |
| Databases, Genetic | 1 | 2019 | 1127 | 0.50 | Why? |
| beta-Lactamases | 4 | 2017 | 759 | 0.42 | Why? |
| High-Throughput Nucleotide Sequencing | 4 | 2019 | 3633 | 0.41 | Why? |
| Klebsiella pneumoniae | 3 | 2017 | 658 | 0.33 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.29 | Why? |
| Genome | 2 | 2018 | 341 | 0.28 | Why? |
| Methicillin-Resistant Staphylococcus aureus | 2 | 2019 | 711 | 0.24 | Why? |
| Plasmids | 4 | 2019 | 840 | 0.23 | Why? |
| Staphylococcal Infections | 3 | 2019 | 1099 | 0.22 | Why? |
| Topotecan | 1 | 2021 | 62 | 0.22 | Why? |
| Topoisomerase I Inhibitors | 1 | 2021 | 63 | 0.22 | Why? |
| DNA Topoisomerases, Type I | 1 | 2021 | 86 | 0.21 | Why? |
| Bacterial Proteins | 3 | 2018 | 1318 | 0.21 | Why? |
| Genome, Bacterial | 3 | 2019 | 446 | 0.21 | Why? |
| Trans-Activators | 2 | 2018 | 170 | 0.20 | Why? |
| Gene Expression Regulation, Bacterial | 2 | 2018 | 143 | 0.20 | Why? |
| Terminator Regions, Genetic | 1 | 2018 | 3 | 0.20 | Why? |
| Bacteremia | 3 | 2019 | 1372 | 0.20 | Why? |
| RNA Polymerase II | 1 | 2018 | 29 | 0.19 | Why? |
| Eukaryota | 1 | 2018 | 31 | 0.18 | Why? |
| Neoplastic Cells, Circulating | 1 | 2018 | 68 | 0.18 | Why? |
| ACTH-Secreting Pituitary Adenoma | 1 | 2017 | 29 | 0.17 | Why? |
| Yeasts | 1 | 2017 | 50 | 0.17 | Why? |
| Proviruses | 1 | 2017 | 82 | 0.17 | Why? |
| Porins | 1 | 2017 | 45 | 0.17 | Why? |
| Chromosomes, Bacterial | 1 | 2017 | 18 | 0.17 | Why? |
| ras Proteins | 1 | 2017 | 37 | 0.17 | Why? |
| Endogenous Retroviruses | 1 | 2017 | 72 | 0.17 | Why? |
| Daptomycin | 1 | 2018 | 64 | 0.17 | Why? |
| Cellular Reprogramming | 1 | 2018 | 117 | 0.17 | Why? |
| Transcriptome | 3 | 2021 | 3466 | 0.17 | Why? |
| Embryonic Stem Cells | 1 | 2017 | 66 | 0.17 | Why? |
| Enterococcus faecium | 1 | 2018 | 95 | 0.17 | Why? |
| Virulence | 3 | 2019 | 2172 | 0.17 | Why? |
| Mutagenesis, Insertional | 1 | 2017 | 92 | 0.17 | Why? |
| DNA, Neoplasm | 1 | 2016 | 56 | 0.17 | Why? |
| Linezolid | 1 | 2018 | 160 | 0.16 | Why? |
| Uterus | 1 | 2016 | 98 | 0.16 | Why? |
| Gene Transfer, Horizontal | 1 | 2016 | 64 | 0.16 | Why? |
| Azabicyclo Compounds | 1 | 2017 | 91 | 0.16 | Why? |
| Ceftazidime | 1 | 2017 | 134 | 0.15 | Why? |
| Neural Stem Cells | 1 | 2017 | 135 | 0.15 | Why? |
| Tumor Suppressor Protein p53 | 1 | 2018 | 310 | 0.15 | Why? |
| Neoplastic Stem Cells | 1 | 2017 | 120 | 0.15 | Why? |
| Vancomycin-Resistant Enterococci | 1 | 2017 | 104 | 0.15 | Why? |
| Genes, Bacterial | 1 | 2017 | 207 | 0.15 | Why? |
| Hematopoietic Stem Cells | 1 | 2018 | 321 | 0.15 | Why? |
| Endometrial Neoplasms | 1 | 2016 | 120 | 0.15 | Why? |
| Cell Communication | 1 | 2017 | 396 | 0.15 | Why? |
| Vancomycin | 1 | 2018 | 328 | 0.14 | Why? |
| beta-Lactam Resistance | 1 | 2016 | 150 | 0.14 | Why? |
| Glioblastoma | 1 | 2017 | 187 | 0.14 | Why? |
| Molecular Epidemiology | 1 | 2019 | 1638 | 0.13 | Why? |
| RNA, Messenger | 2 | 2018 | 5131 | 0.13 | Why? |
| DNA Transposable Elements | 3 | 2017 | 91 | 0.12 | Why? |
| DNA, Bacterial | 1 | 2017 | 835 | 0.12 | Why? |
| Biological Specimen Banks | 1 | 2020 | 1142 | 0.12 | Why? |
| Enterobacteriaceae | 1 | 2016 | 395 | 0.12 | Why? |
| Sequence Analysis, RNA | 2 | 2018 | 2290 | 0.12 | Why? |
| Whole Genome Sequencing | 2 | 2020 | 3239 | 0.12 | Why? |
| Gene Expression Regulation, Viral | 1 | 2017 | 925 | 0.11 | Why? |
| Staphylococcus aureus | 1 | 2018 | 844 | 0.11 | Why? |
| DNA | 1 | 2017 | 778 | 0.11 | Why? |
| Mitochondria | 1 | 2018 | 857 | 0.11 | Why? |
| Extracellular Vesicles | 1 | 2017 | 607 | 0.11 | Why? |
| Enterobacteriaceae Infections | 1 | 2016 | 529 | 0.10 | Why? |
| Military Personnel | 1 | 2020 | 1097 | 0.10 | Why? |
| Brain Neoplasms | 1 | 2017 | 669 | 0.10 | Why? |
| Multiple Organ Failure | 1 | 2020 | 1724 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Cell Proliferation | 1 | 2017 | 1973 | 0.10 | Why? |
| Microbial Sensitivity Tests | 4 | 2019 | 2886 | 0.09 | Why? |
| Carcinoma, Hepatocellular | 1 | 2018 | 1222 | 0.09 | Why? |
| Single-Cell Analysis | 1 | 2018 | 2450 | 0.09 | Why? |
| Chromosome Mapping | 2 | 2018 | 178 | 0.08 | Why? |
| Tissue Donors | 1 | 2017 | 1679 | 0.08 | Why? |
| Gene Expression Profiling | 1 | 2018 | 3788 | 0.08 | Why? |
| Liver | 1 | 2021 | 4007 | 0.08 | Why? |
| Phylogeny | 6 | 2021 | 13341 | 0.08 | Why? |
| Virginia | 2 | 2017 | 228 | 0.08 | Why? |
| Community-Acquired Infections | 1 | 2019 | 2328 | 0.08 | Why? |
| Drug Resistance, Multiple, Bacterial | 3 | 2018 | 1115 | 0.07 | Why? |
| CD8-Positive T-Lymphocytes | 1 | 2021 | 5837 | 0.07 | Why? |
| New York | 2 | 2021 | 2488 | 0.06 | Why? |
| HIV-1 | 1 | 2017 | 3365 | 0.06 | Why? |
| CD4-Positive T-Lymphocytes | 1 | 2017 | 4545 | 0.06 | Why? |
| Mutation | 3 | 2018 | 12376 | 0.06 | Why? |
| CD57 Antigens | 1 | 2021 | 96 | 0.06 | Why? |
| Lung | 2 | 2021 | 31049 | 0.06 | Why? |
| Virus Internalization | 1 | 2020 | 7921 | 0.06 | Why? |
| Humans | 29 | 2021 | 930598 | 0.06 | Why? |
| Pulmonary Embolism | 1 | 2021 | 4775 | 0.06 | Why? |
| Genome, Viral | 2 | 2020 | 13157 | 0.06 | Why? |
| CD56 Antigen | 1 | 2021 | 193 | 0.05 | Why? |
| Inflammation | 2 | 2021 | 13255 | 0.05 | Why? |
| Systemic Inflammatory Response Syndrome | 1 | 2021 | 6653 | 0.05 | Why? |
| Liver Transplantation | 1 | 2017 | 2864 | 0.05 | Why? |
| South Carolina | 1 | 2020 | 134 | 0.05 | Why? |
| Disease Transmission, Infectious | 2 | 2020 | 9044 | 0.05 | Why? |
| Algorithms | 1 | 2017 | 7346 | 0.05 | Why? |
| THP-1 Cells | 1 | 2021 | 374 | 0.05 | Why? |
| Mupirocin | 1 | 2019 | 22 | 0.05 | Why? |
| Autopsy | 2 | 2021 | 3495 | 0.05 | Why? |
| Prokaryotic Cells | 1 | 2018 | 15 | 0.05 | Why? |
| Virus Replication | 1 | 2020 | 14331 | 0.05 | Why? |
| Viral Proteins | 1 | 2017 | 7370 | 0.05 | Why? |
| RNA Transport | 1 | 2017 | 10 | 0.05 | Why? |
| Corticotrophs | 1 | 2017 | 2 | 0.04 | Why? |
| Genomic Islands | 1 | 2017 | 26 | 0.04 | Why? |
| Receptors, Corticotropin-Releasing Hormone | 1 | 2017 | 5 | 0.04 | Why? |
| Vancomycin Resistance | 1 | 2018 | 55 | 0.04 | Why? |
| Cell Line | 3 | 2018 | 12040 | 0.04 | Why? |
| Endosomal Sorting Complexes Required for Transport | 1 | 2017 | 67 | 0.04 | Why? |
| Geography, Medical | 1 | 2020 | 537 | 0.04 | Why? |
| Cross Infection | 1 | 2019 | 8675 | 0.04 | Why? |
| Adrenocorticotropic Hormone | 1 | 2017 | 107 | 0.04 | Why? |
| Coculture Techniques | 1 | 2017 | 258 | 0.04 | Why? |
| Pituitary ACTH Hypersecretion | 1 | 2017 | 44 | 0.04 | Why? |
| Conjugation, Genetic | 1 | 2016 | 12 | 0.04 | Why? |
| Isoenzymes | 1 | 2017 | 127 | 0.04 | Why? |
| Ubiquitin Thiolesterase | 1 | 2017 | 69 | 0.04 | Why? |
| Chlorhexidine | 1 | 2019 | 176 | 0.04 | Why? |
| Mice, SCID | 1 | 2017 | 225 | 0.04 | Why? |
| Adipocytes | 1 | 2017 | 173 | 0.04 | Why? |
| Homologous Recombination | 1 | 2016 | 32 | 0.04 | Why? |
| New York City | 2 | 2021 | 7432 | 0.04 | Why? |
| Xenograft Model Antitumor Assays | 1 | 2017 | 274 | 0.04 | Why? |
| Clone Cells | 1 | 2017 | 312 | 0.04 | Why? |
| Gene Expression | 2 | 2017 | 3332 | 0.04 | Why? |
| Cells, Cultured | 2 | 2017 | 5835 | 0.04 | Why? |
| Therapeutic Irrigation | 1 | 2016 | 167 | 0.04 | Why? |
| Primary Cell Culture | 1 | 2017 | 501 | 0.04 | Why? |
| Mesocricetus | 1 | 2021 | 1847 | 0.04 | Why? |
| Mice | 3 | 2021 | 21357 | 0.04 | Why? |
| Cell Separation | 1 | 2017 | 270 | 0.04 | Why? |
| Pituitary Neoplasms | 1 | 2017 | 130 | 0.04 | Why? |
| Genotyping Techniques | 1 | 2017 | 360 | 0.04 | Why? |
| Down-Regulation | 1 | 2021 | 1416 | 0.04 | Why? |
| Bacterial Typing Techniques | 1 | 2016 | 273 | 0.04 | Why? |
| ErbB Receptors | 1 | 2017 | 320 | 0.04 | Why? |
| Adenoma | 1 | 2017 | 215 | 0.03 | Why? |
| Promoter Regions, Genetic | 1 | 2018 | 823 | 0.03 | Why? |
| Vero Cells | 2 | 2021 | 14117 | 0.03 | Why? |
| Mutation Rate | 1 | 2017 | 382 | 0.03 | Why? |
| Male | 9 | 2021 | 367725 | 0.03 | Why? |
| Carrier Proteins | 1 | 2017 | 513 | 0.03 | Why? |
| Mice, Transgenic | 1 | 2021 | 2739 | 0.03 | Why? |
| Intensive Care Units, Neonatal | 1 | 2019 | 749 | 0.03 | Why? |
| Female | 9 | 2021 | 380317 | 0.03 | Why? |
| Influenza, Human | 1 | 2018 | 10779 | 0.03 | Why? |
| Immunohistochemistry | 1 | 2021 | 2275 | 0.03 | Why? |
| Quarantine | 1 | 2020 | 18418 | 0.03 | Why? |
| DNA Methylation | 1 | 2018 | 688 | 0.03 | Why? |
| Carbapenems | 1 | 2016 | 343 | 0.03 | Why? |
| Animals | 5 | 2021 | 78931 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| China | 1 | 2019 | 50654 | 0.03 | Why? |
| Klebsiella Infections | 1 | 2017 | 466 | 0.03 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2019 | 27595 | 0.03 | Why? |
| Killer Cells, Natural | 1 | 2021 | 2093 | 0.03 | Why? |
| Anti-Bacterial Agents | 3 | 2019 | 10083 | 0.03 | Why? |
| Flow Cytometry | 1 | 2018 | 2393 | 0.02 | Why? |
| Inflammation Mediators | 1 | 2021 | 2654 | 0.02 | Why? |
| Mucocutaneous Lymph Node Syndrome | 1 | 2021 | 1645 | 0.02 | Why? |
| Residence Characteristics | 1 | 2020 | 1927 | 0.02 | Why? |
| Infant, Newborn | 2 | 2021 | 23105 | 0.02 | Why? |
| Base Sequence | 1 | 2017 | 3581 | 0.02 | Why? |
| Blood Coagulation | 1 | 2021 | 2768 | 0.02 | Why? |
| Pneumonia, Viral | 3 | 2020 | 243684 | 0.02 | Why? |
| Genotype | 1 | 2019 | 4697 | 0.02 | Why? |
| Aged | 6 | 2021 | 215776 | 0.02 | Why? |
| Drug Combinations | 1 | 2017 | 3852 | 0.02 | Why? |
| Infant | 2 | 2021 | 30274 | 0.02 | Why? |
| Coronavirus Infections | 3 | 2020 | 253789 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Cause of Death | 1 | 2021 | 4823 | 0.02 | Why? |
| Adult | 6 | 2021 | 244371 | 0.02 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.02 | Why? |
| Macrophages | 1 | 2017 | 2784 | 0.02 | Why? |
| Young Adult | 3 | 2021 | 93724 | 0.02 | Why? |
| Viral Envelope Proteins | 1 | 2017 | 3539 | 0.02 | Why? |
| Aged, 80 and over | 3 | 2021 | 88759 | 0.02 | Why? |
| Drug Therapy, Combination | 1 | 2018 | 7268 | 0.02 | Why? |
| Middle Aged | 5 | 2021 | 270681 | 0.02 | Why? |
| Public Health Surveillance | 1 | 2016 | 3129 | 0.01 | Why? |
| Disease Progression | 1 | 2021 | 13580 | 0.01 | Why? |
| Nasopharynx | 1 | 2021 | 10224 | 0.01 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.01 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.01 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2020 | 11367 | 0.01 | Why? |
| Pandemics | 4 | 2021 | 389249 | 0.01 | Why? |
| Child | 2 | 2021 | 70012 | 0.01 | Why? |
| Host-Pathogen Interactions | 1 | 2021 | 11041 | 0.01 | Why? |
| Viral Load | 1 | 2021 | 15850 | 0.01 | Why? |
| Hospitals | 1 | 2019 | 11793 | 0.01 | Why? |
| Mass Screening | 1 | 2019 | 8005 | 0.01 | Why? |
| Cytokines | 1 | 2021 | 15010 | 0.01 | Why? |
| Tertiary Care Centers | 1 | 2016 | 8248 | 0.01 | Why? |
| Child, Preschool | 1 | 2021 | 36283 | 0.01 | Why? |
| Prospective Studies | 1 | 2016 | 43301 | 0.01 | Why? |
| Risk Factors | 1 | 2020 | 71621 | 0.01 | Why? |
| Adolescent | 1 | 2021 | 86841 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2016 | 53120 | 0.01 | Why? |
Sebra's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(207)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(283)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_